|
United
Nations Environment Programme |
Decision XII/2(3)
Measures by Parties to facilitate the transition
to chlorofluorocarbon-free metered-dose inhalers
Pursuant to paragraph 3 of Decision XII/2 of the Twelfth Meeting of the Parties on measures to facilitate the transition to chlorofluorocarbon-free metered-dose inhalers, the following Parties have determined that the following CFC-MDI active ingredients are no longer essential and thereby not authorised for domestic use:
List of Non-Essential Substances
Last Update: 28 December 2005
| Table 1 | Short Acting Beta Agonist Bronchodilators | |||||
| Country | Salbutamol |
Terbutaline | Fenoterol | Orciprenaline |
Reproterol | Carbuterol |
| Austria | X | X |
X | X | X |
X |
| Belgium | X |
X | X | X |
X | X |
| Cyprus | x | |||||
| Czech Republic | X |
X | X | X |
X | X |
| Denmark | X | X |
X | X | X | |
| Estonia | X | X |
X | X | X |
X |
| Finland | X | |||||
| France |
X | |||||
| Germany | X | X |
X | X | X |
X |
| Greece | X |
X | X | X |
X | X |
| Hungary | X | X |
X | X | X |
X |
| Ireland | X | |||||
| Italy |
X | |||||
| Latvia | X | X |
X | X | X |
X |
| Lithuania |
X | X | X |
X | X | X |
| Luxembourg | X | |||||
|
Malta | X | |||||
| Netherlands | X |
X | X | X |
X | X |
| Poland | X | |||||
| Portugal |
X | X | X |
X | X | X |
| Norway | X | X |
X | X | X |
X |
| Slovak Republic | X |
X | X | X |
X | X |
| Slovenia | X | X |
X | X | X |
X |
| Spain |
x | |||||
| Sweden | X | |||||
|
United Kingdom | X | |||||
| Table 1 (cont.) | Short Acting Beta Agonist Bronchodilators | ||||
| Country | Hexoprenaline | Pirbuterol | Clenbuterol | Bitolterol | Procaterol |
| Austria | X | X | X | X | X |
|
Belgium | X | X |
X | X | X |
| Cyprus | |||||
| Czech Republic | X |
X | X | X |
X |
| Denmark | X |
X | X | X |
X |
| Estonia | X |
X | X | X |
X |
| Finland | |||||
| France | |||||
| Germany |
X | X | X |
X | X |
| Greece |
X | X | X |
X | X |
| Hungary |
X | X | X |
X | X |
| Ireland | |||||
| Italy | |||||
| Latvia |
X | X | X |
X | X |
| Lithuania |
X | X | X |
X | X |
| Luxembourg | |||||
|
Malta | |||||
| Netherlands | X | X | X | X | X |
| Poland | |||||
| Portugal | X | X | X | X | X |
| Norway |
X | X | X |
X | X |
| Slovak Republic |
X | X | X |
X | X |
| Slovenia |
X | X | X |
X | X |
| Spain | |||||
| Sweden | |||||
| United Kingdom | |||||
|
Table 2 | Inhaled steroids | |||||
|
Country | Beclomethasone |
Dexamethasone | Flunisolide |
Fluticasone | Budesonide |
Triamcinolone |
| Austria | ||||||
| Belgium | X | X |
X | X | X |
X |
| Cyprus | ||||||
| Czech Rep | X | X | X |
X | X | X |
| Denmark | X | X | ||||
| Estonia | X |
X | X | X |
X | X |
|
Finland | X | X | ||||
| France | X | X | ||||
| Germany | X | X | X |
X | X | X |
| Greece | ||||||
| Hungary | X |
X | X | X |
X | X |
|
Ireland | X | X | ||||
| Italy | X | X | X | |||
| Latvia | X |
X | X | X |
X | X |
|
Lithuania | ||||||
|
Luxembourg | ||||||
|
Malta |
X | X | ||||
| Poland | ||||||
|
Portugal | X | X | ||||
| The Netherlands |
X | X | X |
X | X | X |
| Norway | ||||||
| Slovak Republic | X |
X | X | X |
X | X |
|
Slovenia | X | X |
X | X | X |
X |
| Spain |
X | X | ||||
| Sweden |
X | X | X |
X | X | |
| United Kingdom | X | |||||
| Table 3 | Non steroidal anti inflammatories | |||||
| Country | Cromoglicic acid |
Nedrocromil | ||||
|
Austria | ||||||
|
Belgium | X | X | ||||
|
Cyprus | ||||||
| Czech Rep | X | X | ||||
|
Denmark | X | X | ||||
|
Estonia | X | X | ||||
|
Finland | X | X | ||||
|
France | X | X | ||||
|
Germany | X | X | ||||
|
Greece | X | X | ||||
|
Hungary | ||||||
|
Ireland | ||||||
|
Italy | ||||||
| Latvia |
X | X | ||||
| Lithuania | ||||||
| Luxembourg | ||||||
| Malta | ||||||
|
Poland | ||||||
| Portugal | X | |||||
|
The Netherlands | X |
X | ||||
| Norway | ||||||
| Slovak Republic | X |
X | ||||
| Slovenia | X |
X | ||||
| Spain |
X | |||||
| Sweden | ||||||
| United Kingdom | ||||||
| Table 4 | Anticholinergic Bronchodilators | |||||
| Country | Ipratropium bromide |
Oxitropium Bromide | ||||
|
Austria | ||||||
|
Belgium | X | X | ||||
|
Cyprus | X | X | ||||
|
Czech Rep | X |
X | ||||
| Denmark | X |
X | ||||
| Estonia | X |
X | ||||
| Finland | X |
X | ||||
| France | ||||||
| Germany | X |
X | ||||
| Greece | X |
X | ||||
| Hungary | X |
X | ||||
| Ireland | X |
X | ||||
| Italy | ||||||
| Latvia | ||||||
| Lithuania | ||||||
| Luxembourg | ||||||
| Malta | X |
X | ||||
| Netherlands | X |
X | ||||
| Poland | ||||||
| Portugal | X | |||||
| Norway | ||||||
| Slovak Republic | X |
X | ||||
| Slovenia | ||||||
| Spain | X |
X | ||||
| Sweden | X |
X | ||||
| United Kingdom |
X | X | ||||
|
Table 5 | Long Acting Beta Agonist Bronchodilators | |||||
| Country | Formoterol |
Salmeterol | ||||
| Austria | ||||||
| Belgium | ||||||
| Cyprus | ||||||
| Czech Rep | ||||||
| Denmark | ||||||
| Estonia | ||||||
| Finland | ||||||
| France | ||||||
| Germany | X |
X | ||||
| Greece | ||||||
| Hungary | ||||||
| Ireland | ||||||
| Italy | X | |||||
| Latvia | ||||||
| Lithuania | ||||||
| Luxembourg | ||||||
| Malta | ||||||
|
Netherlands | ||||||
|
Poland | ||||||
|
Portugal | ||||||
|
Norway | ||||||
|
Slovak Republic | ||||||
|
Slovenia | ||||||
|
Spain | ||||||
| Sweden | ||||||
| United Kingdom | ||||||
| Table 6 | Combinations of active ingredients in a single MDI | |||||
| Country | ||||||
| Austria | ||||||
| Belgium | ||||||
| Cyprus | ||||||
| Czech Rep | ||||||
| Denmark | ||||||
| Estonia | ||||||
| Finland | ||||||
| France | ||||||
| Germany | X | |||||
| Greece | ||||||
| Hungary | ||||||
| Ireland | ||||||
| Italy | ||||||
|
Latvia | ||||||
|
Lithuania | ||||||
|
Luxembourg | ||||||
|
Malta | ||||||
| Netherlands | ||||||
| Poland | ||||||
| Portugal | ||||||
| Norway | ||||||
| Slovak Republic | ||||||
| Slovenia | ||||||
| Spain | ||||||
|
Sweden | ||||||
|
United Kingdom | ||||||
